Expert Discusses ZUMA-2 Trial Investigating CAR T-Cell Therapy in MCL – Targeted Oncology
Targeted Oncology |
Expert Discusses ZUMA-2 Trial Investigating CAR T-Cell Therapy in MCL
Targeted Oncology Locke: It is important that people are aware of existing trials, not only for MCL but also for DLBCL, so they can determine whether their patients are eligible for a referral to a center that has clinical trials, especially in the CAR T-cell space and … |
